AMG National Trust Bank Sells 4,050 Shares of The Clorox Company (NYSE:CLX)

AMG National Trust Bank cut its holdings in shares of The Clorox Company (NYSE:CLX) by 55.7% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,225 shares of the company’s stock after selling 4,050 shares during the quarter. AMG National Trust Bank’s holdings in Clorox were worth $525,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the business. Mizuho Securities USA LLC boosted its position in Clorox by 46,877.8% during the third quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock valued at $733,095,000 after purchasing an additional 4,490,421 shares during the last quarter. Nuance Investments LLC boosted its holdings in shares of Clorox by 150.6% in the 2nd quarter. Nuance Investments LLC now owns 1,597,674 shares of the company’s stock valued at $218,035,000 after buying an additional 960,094 shares during the last quarter. Van ECK Associates Corp grew its stake in shares of Clorox by 2.2% in the third quarter. Van ECK Associates Corp now owns 1,492,717 shares of the company’s stock valued at $237,372,000 after buying an additional 31,510 shares in the last quarter. Bank of New York Mellon Corp increased its holdings in Clorox by 14.4% during the second quarter. Bank of New York Mellon Corp now owns 961,387 shares of the company’s stock worth $131,200,000 after buying an additional 120,716 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its position in Clorox by 11.9% during the second quarter. Dimensional Fund Advisors LP now owns 802,237 shares of the company’s stock worth $109,483,000 after acquiring an additional 85,529 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Clorox

In other news, EVP Angela C. Hilt sold 1,733 shares of the business’s stock in a transaction on Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the transaction, the executive vice president now owns 13,471 shares of the company’s stock, valued at approximately $2,229,719.92. The trade was a 11.40 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.57% of the stock is currently owned by insiders.

Clorox Trading Down 0.6 %

Shares of CLX stock opened at $168.16 on Wednesday. The stock has a market cap of $20.81 billion, a P/E ratio of 58.59, a price-to-earnings-growth ratio of 3.10 and a beta of 0.41. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $169.21. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The stock has a 50 day simple moving average of $162.56 and a 200 day simple moving average of $147.94.

Clorox (NYSE:CLX) last released its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The firm had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same period in the prior year, the company posted $0.49 EPS. The company’s revenue was up 27.0% compared to the same quarter last year. On average, research analysts predict that The Clorox Company will post 6.85 earnings per share for the current fiscal year.

Clorox Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be given a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 2.90%. Clorox’s payout ratio is presently 170.04%.

Analyst Ratings Changes

Several research firms have recently weighed in on CLX. BNP Paribas upgraded shares of Clorox to a “strong sell” rating in a research note on Friday, September 6th. Evercore ISI dropped their price objective on Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a research note on Monday, October 14th. Jefferies Financial Group upgraded Clorox from a “hold” rating to a “buy” rating and lifted their target price for the stock from $174.00 to $187.00 in a research note on Tuesday, October 1st. TD Cowen upgraded Clorox from a “sell” rating to a “hold” rating and increased their price target for the company from $155.00 to $170.00 in a research note on Wednesday, November 6th. Finally, Citigroup upped their price objective on shares of Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a report on Friday, September 6th. Five equities research analysts have rated the stock with a sell rating, ten have given a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $155.00.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.